These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 31419587

  • 1. In vitro evaluation of Pseudomonas aeruginosa chronic lung infection models: Are agar and calcium-alginate beads interchangeable?
    Torres BGS, Awad R, Marchand S, Couet W, Tewes F.
    Eur J Pharm Biopharm; 2019 Oct; 143():35-43. PubMed ID: 31419587
    [Abstract] [Full Text] [Related]

  • 2. In vivo efficacy of a dry powder formulation of ciprofloxacin-copper complex in a chronic lung infection model of bioluminescent Pseudomonas aeruginosa.
    Tewes F, Bahamondez-Canas TF, Moraga-Espinoza D, Smyth HDC, Watts AB.
    Eur J Pharm Biopharm; 2020 Jul; 152():210-217. PubMed ID: 32442738
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy of Aerosolized Rifaximin versus Tobramycin for Treatment of Pseudomonas aeruginosa Pneumonia in Mice.
    Kirby BD, Al Ahmar R, Withers TR, Valentine ME, Valentovic M, Long TE, Gaskins JR, Yu HD.
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010865
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Screening, cloning and expression of a novel alginate lyase gene from P. aeruginosa TAG 48 and its antibiofilm effects on P. aeruginosa biofilm.
    Tavafi H, Ali AA, Ghadam P, Gharavi S.
    Microb Pathog; 2018 Nov; 124():356-364. PubMed ID: 30118807
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of Ciprofloxacin and Its Copper Complex against Pseudomonas aeruginosa Biofilms.
    Tewes F, Bahamondez-Canas TF, Smyth HDC.
    AAPS PharmSciTech; 2019 May 29; 20(5):205. PubMed ID: 31144198
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Tailoring of alginate-gelatin microspheres properties for oral Ciprofloxacin-controlled release against Pseudomonas aeruginosa.
    Islan GA, Castro GR.
    Drug Deliv; 2014 Dec 29; 21(8):615-26. PubMed ID: 24401147
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Targeted treatment for biofilm-based infections using PEGylated tobramycin.
    Ding L, Wang G, Wang J, Peng Y, Cai S, Khan SU, Cui Z, Zhang X, Wu C, Smyth H.
    J Control Release; 2024 Aug 29; 372():43-58. PubMed ID: 38866243
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.